hypertrophic cardiomyopathyMicroscopy demonstrates a variety of abnormalities, including myocyte hypertrophy, myocardial fibre disarray (myocytes are not in parallel but lay chaotically intersected), interstitial and perivascular fibrosis, and intimal and medial hypertrophy in intramural arteries leading to ...
travels the body). When it does, it is referred to as hypertrophic obstructive cardiomyopathy (HOCM). HOCM is a relatively common finding in young people who experience sudden cardiac arrest. HOCM is often associated with a mitral valve condition called SAM (which stands for Systolic Anterior Mot...
Data on the prevalence of hypertrophic cardiomyopathy (HCM), characteristics of patients with HCM, and treatment patterns in Japan are limited. This study aimed to estimate the prevalence of HCM and describe the patient characteristics, treatment patterns, and utilization of medical expense subsidies in...
A 50-year-old male patient with hypertrophic cardiomyopathy and atrial fibrillation was anticoagulated, with warfarin following insertion of a cardioverter defibrillator. He became markedly over anticoagulated after standard moderate induction doses of warfarin. His baseline prothrombin time was prolonged an...
Remarkable advancements have been made in understanding the pathophysiology of hypertrophic cardiomyopathy (HCM), since the first implantable cardioverter defibrillator (ICD) was placed in a human, more than 25 years ago to prevent sudden cardiac death (SCD). ICD has become the cornerstone in the ma...
2005;2(12):659-662. © 2005 Nature Publishing Group Cite this: Ambulatory Monitoring of Aborted Sudden Cardiac Death in a Patient with Hypertrophic Cardiomyopathy - Medscape - Dec 01, 2005. Summary The Case Discussion of Diagnosis Treatment and Management Conclusion References...
[IEEE 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) - Belfast, United Kingdom (2014.11.2-2014.11.5)] 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) - Identifying hypertrophic cardiomyopathy patient ...
Paradoxical Effects of Interatrial Conduction Delay in a Hypertrophic Cardiomyopathy Patient in the Long-Term: Time is a Great Healer 来自 NCBI 喜欢 0 阅读量: 26 作者:T Bauernfeind,K Caliskan,BVRN W.,FJT Cate,L Dabiri,ND Groot,L Jordaens,T Szili-Torok ...
Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young individuals. A potential role of mtDNA mutations in HCM is known. However, the underlying molecular mechanisms linking mtDNA mutations to HCM remain poorly understood due to lack of cell and animal models....
Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project Elizabeth Ormondroyd Christopher Grace Hugh Watkins European Journal of Human Genetics (2024) Transcriptomic and genetic profiling in a spontaneous non-human primate model of hypertrophic cardiomyo...